Voelkl, Jakob
Lang, Florian
Eckardt, Kai-Uwe
Amann, Kerstin
Kuro-o, Makoto
Pasch, Andreas
Pieske, Burkert
Alesutan, Ioana
Funding for this research was provided by:
Berlin Institute of Health
Else Kröner-Fresenius-Stiftung
Deutsche Forschungsgemeinschaft (AL2054/1-1, VO2259/2-1)
Deutsches Zentrum für Herz-Kreislaufforschung
Article History
Received: 30 September 2018
Revised: 13 February 2019
Accepted: 21 February 2019
First Online: 18 March 2019
Compliance with ethical standards
:
: AP is an employee and stockholder of Calciscon AG which commercializes the Calcification propensity test. Otherwise, the authors declare that they have no conflict of interest.